InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 07/11/2017 8:43:01 AM

Tuesday, July 11, 2017 8:43:01 AM

Post# of 27623
OCUL - 6.49 Pre-market now at 7.72/7.84

Ocular Therapeutix(TM) Submits Amendment to Potentially Extend Review for DEXTENZA(TM) New Drug Application (NDA)



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.